Solve Therapeutics

Solve Therapeutics is a clinical-stage biopharmaceutical company advancing a pipeline of next-generation ADCs and a novel diagnostic platform for solid tumors. Solve is engineering therapeutics designed to safely and effectively offer benefit to patients with life-threatening cancers with its proprietary CloakLink™ hydrophilic linker system, which focuses on selectively expressed tumor antigens. Its diagnostic approach offers the potential of precise, noninvasive patient selection.